Vitamin D deficiency and secondary hyperparathyroidism are associated with more rapid bone decline in older men. In older men, lower 25-hydroxycholecalciferol (25OHD) and higher parathyroid hormone ...

The 2017 KDIGO guideline for CKD-MBD may be too conservative, according to investigators. Observational study data suggest that it may be possible to prevent development of secondary ...

Long-term treatment with TransCon parathyroid hormone (PTH), a replacement therapy for hypoparathyroidism, demonstrates sustained efficacy and safety in patients with hypoparathyroidism over 52 weeks, ...

Primary hyperparathyroidism occurs when the parathyroid glands produce too much parathyroid hormone (PTH). This can lead to health complications. Primary hyperparathyroidism is a relatively common ...

Please provide your email address to receive an email when new articles are posted on . Trevisan and colleagues conducted an observational study with data from 2,418 adults from the Progetto Veneto ...

Parathyroid hormone (PTH) treatment mainly treats hypoparathyroidism (too little parathyroid hormone). Symptoms can include tingling, muscle cramps, and in severe cases, seizures. Recombinant human ...

Hypoparathyroidism happens when your parathyroid glands don’t make enough parathyroid hormone (PTH). Low PTH can cause low calcium and high phosphate levels. While there’s currently no cure for ...

In patients who underwent total thyroidectomy, parathyroid hormone (PTH) levels less than 10.10 pg/mL measured 6 hours after surgery helped accurately identify those at risk of developing transient ...

(RTTNews) - Ascendis Pharma A/S (ASND), a clinical-stage biopharmaceutical company focusing on endocrinology rare disease, is all set to report results from a phase II study of TransCon PTH for adult ...

Hypothyroidism is when the thyroid gland does not make enough thyroid hormone. Hypoparathyroidism is comparatively rare, where the parathyroid glands behind the thyroid do not produce enough ...